Los Angeles, CA – December 6, 2013 – The U.S. District Court for the Central District of California has ruled in favor of firm clients Xiamen Kingdomway Group Company (“XKGC”) and Pacific Rainbow International Inc. (“PRI”) on their motion for summary judgment of noninfringement of U.S. Patent No. 7,910,340. The Court concluded that XKGC’s process for manufacturing Coenzyme Q10 does not infringe the ‘340 patent. The litigation, brought by Kaneka Corporation, is Case No. 2:11-cv-02389-MRP(SSx) in the Central District of California.
Central District of California Rules in Favor of Firm Clients XKGC and PRI on Summary Judgment of Noninfringement